• Home
  • PharmTech.com
  • About
  • Contact
  • Newsletters
  • Subscribe/RSS

About

Welcome to PharmTech Talk, the blog of Pharmaceutical Technology, the authoritative source of peer-reviewed research and expert analyses for scientists, engineers, and managers engaged in process development, manufacturing, formulation and drug delivery, API synthesis, analytical technology and testing, packaging, IT, outsourcing, and regulatory compliance in the pharmaceutical and biotechnology industries.

Pharmaceutical Technology welcomes manuscripts on subjects pertinent to all aspects of applied research and development, scale-up, and manufacturing technologies for the pharmaceutical industry. See the Guidelines for Authors page on PharmTech.com for more information on article contributions.

Get insight into the latest industry news and trends from the editors of Pharmaceutical Technology and occasional guest bloggers. We also welcome contributed posts here on PharmTech Talk. For information on contributing a blog post, contact Angie Drakulich, the managing editor, at adrakulich@advanstar.com. We look forward to hearing from you—leave a comment or feel free to email us!

Angie Drakulich
Editorial Director
adrakulich@advanstar.com

Patricia Van Arnum
Executive Editor
pvanarnum@advanstar.com

Susan Haigney
Managing Editor
shaigney@advanstar.com

Amy Ritter
Scientific Editor
aritter@advanstar.com

Jennifer Markarian
Manufacturing Editor
Jmarkarian@advanstar.com

Stephanie Sutton
Community Manager

ssutton@advanstar.com

Chris Allen
Associate Editor
callen@advanstar.com

No Comment

Comments are closed.

Posting your comment.

  • Categories

  • Authors

    • A. Nair, Mumbai correspondent (4)
    • Adeline Siew (24)
    • Alexis Pellek (87)
    • Amy Ritter (77)
    • Angie Drakulich (226)
    • Christopher Allen (11)
    • Corrine Lawrence, PharmTech Europe (2)
    • Daniel R. Matlis, president of Axendia (1)
    • Erik Greb (160)
    • Fedra Pavlou, PharmTech Europe (6)
    • Girish Malhotra, PE, president of EPCOT International (1)
    • GuestBlogger (2)
    • Helen Disney (1)
    • Jamie Carpenter, multimedia producer, Advanstar (1)
    • Jennifer Markarian (25)
    • Jill Wechsler, Washington editor (30)
    • Jlaw (3)
    • Joe Acker, SOCMA president (1)
    • Julian Upton (8)
    • kshaw (1)
    • Maribel Rios (61)
    • Mark Lowery (1)
    • Michelle Hoffman (13)
    • Patricia Van Arnum (174)
    • Peter Houston (3)
    • PvonDyck (1)
    • Reflector (4)
    • Rich Whitworth (12)
    • Rita Peters (2)
    • RPaul (4)
    • SConnor (1)
    • Stephanie Sutton, PharmTech Europe (106)
    • Susan Haigney (17)
    • Various Attendees (2)
  • Recent Posts

    • Patent Settlements Become More Risky
    • Praise and Perils for Biotechnology Patent Policy
    • Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
    • Quality Focus: Ensuring Raw Material Transparency
    • Advertising of Prescription Drugs – Keeping it Honest and Balanced
  • PharmTech Poll

    Biosimilars
    What do you think is the main challenge facing manufacturers seeking to launch a new biosimilar?
    Vote Here
  • Popular Tags

    AstraZeneca biopharmaceuticals Biosimilars biotechnology cancer clinical trials Congress contamination counterfeiting Drug Delivery Eli Lilly FDA FDA inspections generic GlaxoSmithKline healthcare heparin innovation J&J Manufacturing marketing Merck mergers and acquisitions Novartis Obama Outsourcing patent patient Pfizer pharmaceuticals PhRMA pipeline QbD R&D recall Regulation research and development Roche Sanofi Senate social media supply chain UK vaccine Wyeth
  • RSS From PharmTech.com

    • GSK Receives Offer for its Thrombosis Brands and Related Manufacturing Site
    • Pfizer Wins Multibillion-Dollar Settlement from Teva and Sun for Infringement of Protonix Patent
    • AstraZeneca Selects Cambridge, UK for New Global R&D Center and Corporate HQ
    • J&J to Acquire Aragon Pharmaceuticals
    • Elan Initiates Formal Sale Process of Company
  • Blogroll

    • AAPS Blog
    • Applied Clinical Trials Blog
    • Beaker’s Blog
    • cafepharma
    • Compliance Zen
    • Eye on FDA
    • FDA Matters
    • FDA Transparency Blog
    • FDA Voice
    • GxP Perspectives
    • In the Pipeline
    • InternetDrugNews
    • Life Science Panorama
    • Pharmalot
    • PharmExecBlog
    • PhRMA's Blog
    • SOCMA President Lawrence D. Sloan’s Blog
    • The PhRMA Blog-Catalyst
    • WSJ’s Health Blog
  • Archives

Copyright © 2013 PharmTech Talk
WordPress Theme based on Light Theme